tirzepatide surpass cvot cardiovascular event risk assessment: a pre-specified meta-analysis ACC 26: SURPASS-CVOT - Tirzepatide

A successful card swipe at checkout doesnt prove your plan will accept the charge either some employers have warned members that GLP-1 transactions may process and still be clawed back later

These gastrointestinal effects usually diminish over time but can be troublesome for some patients

Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review

Zhang D, Tong X, VanDommelen K, Gupta N, Stamper K, Brady GF, Meng Z, Lin J, Rui L, Omary MB, Yin L (2017) Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity

Novo Nordisk (n.d.)

Selective GH stimulation thats commonly discussed as having minimal spillover into other pituitary hormones in research settings